These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33446646)

  • 1. A cortical immune network map identifies distinct microglial transcriptional programs associated with β-amyloid and Tau pathologies.
    Patrick E; Olah M; Taga M; Klein HU; Xu J; White CC; Felsky D; Agrawal S; Gaiteri C; Chibnik LB; Mostafavi S; Schneider JA; Bennett DA; Bradshaw EM; De Jager PL
    Transl Psychiatry; 2021 Jan; 11(1):50. PubMed ID: 33446646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
    Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
    Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial activation and tau propagate jointly across Braak stages.
    Pascoal TA; Benedet AL; Ashton NJ; Kang MS; Therriault J; Chamoun M; Savard M; Lussier FZ; Tissot C; Karikari TK; Ottoy J; Mathotaarachchi S; Stevenson J; Massarweh G; Schöll M; de Leon MJ; Soucy JP; Edison P; Blennow K; Zetterberg H; Gauthier S; Rosa-Neto P
    Nat Med; 2021 Sep; 27(9):1592-1599. PubMed ID: 34446931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroticism alters the transcriptome of the frontal cortex to contribute to the cognitive decline and onset of Alzheimer's disease.
    De Jager CH; White CC; Bennett DA; Ma Y
    Transl Psychiatry; 2021 Feb; 11(1):139. PubMed ID: 33627625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
    Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A
    J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes.
    Kim DW; Tu KJ; Wei A; Lau AJ; Gonzalez-Gil A; Cao T; Braunstein K; Ling JP; Troncoso JC; Wong PC; Blackshaw S; Schnaar RL; Li T
    Mol Neurodegener; 2022 Dec; 17(1):83. PubMed ID: 36536457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease.
    Gerrits E; Brouwer N; Kooistra SM; Woodbury ME; Vermeiren Y; Lambourne M; Mulder J; Kummer M; Möller T; Biber K; Dunnen WFAD; De Deyn PP; Eggen BJL; Boddeke EWGM
    Acta Neuropathol; 2021 May; 141(5):681-696. PubMed ID: 33609158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies.
    Fixemer S; Ameli C; Hammer G; Salamanca L; Uriarte Huarte O; Schwartz C; Gérardy JJ; Mechawar N; Skupin A; Mittelbronn M; Bouvier DS
    Acta Neuropathol Commun; 2022 Mar; 10(1):36. PubMed ID: 35296366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model.
    Ghosh S; Wu MD; Shaftel SS; Kyrkanides S; LaFerla FM; Olschowka JA; O'Banion MK
    J Neurosci; 2013 Mar; 33(11):5053-64. PubMed ID: 23486975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology.
    Paasila PJ; Davies DS; Kril JJ; Goldsbury C; Sutherland GT
    Brain Pathol; 2019 Nov; 29(6):726-740. PubMed ID: 30803086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.
    Scholtzova H; Chianchiano P; Pan J; Sun Y; Goñi F; Mehta PD; Wisniewski T
    Acta Neuropathol Commun; 2014 Sep; 2():101. PubMed ID: 25178404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease.
    Mostafavi S; Gaiteri C; Sullivan SE; White CC; Tasaki S; Xu J; Taga M; Klein HU; Patrick E; Komashko V; McCabe C; Smith R; Bradshaw EM; Root DE; Regev A; Yu L; Chibnik LB; Schneider JA; Young-Pearse TL; Bennett DA; De Jager PL
    Nat Neurosci; 2018 Jun; 21(6):811-819. PubMed ID: 29802388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.
    Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK
    Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
    Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I
    Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated biology approach reveals molecular and pathological interactions among Alzheimer's Aβ42, Tau, TREM2, and TYROBP in Drosophila models.
    Sekiya M; Wang M; Fujisaki N; Sakakibara Y; Quan X; Ehrlich ME; De Jager PL; Bennett DA; Schadt EE; Gandy S; Ando K; Zhang B; Iijima KM
    Genome Med; 2018 Mar; 10(1):26. PubMed ID: 29598827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model.
    Wang H; Li Y; Ryder JW; Hole JT; Ebert PJ; Airey DC; Qian HR; Logsdon B; Fisher A; Ahmed Z; Murray TK; Cavallini A; Bose S; Eastwood BJ; Collier DA; Dage JL; Miller BB; Merchant KM; O'Neill MJ; Demattos RB
    Mol Neurodegener; 2018 Dec; 13(1):65. PubMed ID: 30558641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.